(Q47387633)

English

Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker.

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Suzanne McElwaine

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Claire Mulligan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jürgen Groet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Monica Spinelli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Andrea Rinaldi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gareth Denyer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Afua Mensah

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Simona Cavani

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Chiara Baldo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Franca Dagna-Bricarelli

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ian Hann

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Finbarr E Cotter

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dean Nizetic

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

125

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

729-742

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15180862%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Natural history of GATA1 mutations in Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Transcriptional regulation of erythropoiesis: an affair involving multiple partners

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Defining the specific physiological requirements for c-Myc in T cell development.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

MycN sensitizes neuroblastoma cells for drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Simultaneous expression of different immunogenic antigens in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

The DNA sequence of human chromosome 21

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

X-linked thrombocytopenia caused by a novel mutation of GATA-1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Diversification of haematopoietic stem cells to specific lineages.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Why does stage 4s neuroblastoma regress spontaneously?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

GATA-1-mediated proliferation arrest during erythroid maturation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Core-binding factors in haematopoiesis and leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

PRAME gene expression in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Down syndrome and the transient myeloproliferative disorder: why is it transient?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04982.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47387633&oldid=1252692082"